182 related articles for article (PubMed ID: 21984591)
1. Beryllium: a paradigm for occupational lung disease and its prevention.
Kreiss K
Occup Environ Med; 2011 Nov; 68(11):787-8. PubMed ID: 21984591
[No Abstract] [Full Text] [Related]
2. HLA-DPB1 E69 genotype and exposure in beryllium sensitisation and disease.
Crooks J; Mroz MM; VanDyke M; McGrath A; Schuler C; McCanlies EC; Virji MA; Rosenman KD; Rossman M; Rice C; Monos D; Fingerlin TE; Maier LA
Occup Environ Med; 2022 Feb; 79(2):120-126. PubMed ID: 34535537
[TBL] [Abstract][Full Text] [Related]
3. Lack of an Exposure Response and Interaction With HLA-DPβ1 and DRβ1 Polymorphisms in the Development of Beryllium Toxicity in a High Beryllium Exposure Cohort.
Widyaningsih V; Rosenman K; Reilly MJ; Wang L; Pathak DR; Gardiner JC; Rice C; Monos D; Rossman M
J Occup Environ Med; 2020 Jan; 62(1):64-73. PubMed ID: 31743304
[TBL] [Abstract][Full Text] [Related]
4. Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry.
Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Cragle DL; Tankersley WG; Wells SM; Newman LS; Maier LA
Occup Environ Med; 2011 Nov; 68(11):842-8. PubMed ID: 21460389
[TBL] [Abstract][Full Text] [Related]
5. Prevention of beryllium sensitization and chronic beryllium disease.
Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW
J Occup Environ Hyg; 2006 Apr; 3(4):D42-3. PubMed ID: 16507518
[No Abstract] [Full Text] [Related]
6. Enhanced preventive programme at a beryllium oxide ceramics facility reduces beryllium sensitisation among new workers.
Cummings KJ; Deubner DC; Day GA; Henneberger PK; Kitt MM; Kent MS; Kreiss K; Schuler CR
Occup Environ Med; 2007 Feb; 64(2):134-40. PubMed ID: 17043076
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization.
McCanlies EC; Schuler CR; Kreiss K; Frye BL; Ensey JS; Weston A
J Occup Environ Med; 2007 Apr; 49(4):446-52. PubMed ID: 17426528
[TBL] [Abstract][Full Text] [Related]
8. Toxic beryllium and genetic testing.
Danneskiold J
Environ Health Perspect; 2001 May; 109(5):A200. PubMed ID: 11401769
[No Abstract] [Full Text] [Related]
9. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease.
Maier L; Martyny J; Mroz M; McGrath D; Lympany P; duBois R; Zhang L; Murphy J; Newman LS
Chest; 2002 Mar; 121(3 Suppl):81S. PubMed ID: 11893702
[No Abstract] [Full Text] [Related]
10. Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.
Fontenot AP; Falta MT; Kappler JW; Dai S; McKee AS
J Immunol; 2016 Jan; 196(1):22-7. PubMed ID: 26685315
[TBL] [Abstract][Full Text] [Related]
11. Research to Practice Implications of High-Risk Genotypes for Beryllium Sensitization and Disease.
Kreiss K; Fechter-Leggett ED; McCanlies EC; Schuler CR; Weston A
J Occup Environ Med; 2016 Sep; 58(9):855-60. PubMed ID: 27414009
[TBL] [Abstract][Full Text] [Related]
12. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
Kreiss K; Wasserman S; Mroz MM; Newman LS
J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
[TBL] [Abstract][Full Text] [Related]
13. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers.
Van Dyke MV; Martyny JW; Mroz MM; Silveira LJ; Strand M; Fingerlin TE; Sato H; Newman LS; Maier LA
Am J Respir Crit Care Med; 2011 Jun; 183(12):1680-8. PubMed ID: 21471109
[TBL] [Abstract][Full Text] [Related]
14. [Management of occupational health for adverse health effects of beryllium and its compounds in workplaces - Recent trends and issues in Japan].
Toyooka T; Koda S
Sangyo Eiseigaku Zasshi; 2021 Mar; 63(2):31-42. PubMed ID: 32788509
[TBL] [Abstract][Full Text] [Related]
15. Genetic susceptibility to beryllium: a case-referent study of men and women of working age with sarcoidosis or other chronic lung disease.
Cherry N; Beach J; Burstyn I; Parboosingh J; Schouchen J; Senthilselvan A; Svenson L; Tamminga J; Yiannakoulias N
Occup Environ Med; 2015 Jan; 72(1):21-7. PubMed ID: 25305207
[TBL] [Abstract][Full Text] [Related]
16. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
McCawley MA; Kent MS; Berakis MT
Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
[TBL] [Abstract][Full Text] [Related]
17. Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.
Fontenot AP; Newman LS; Kotzin BL
Clin Immunol; 2001 Jul; 100(1):4-14. PubMed ID: 11414740
[No Abstract] [Full Text] [Related]
18. Systematic review: Progression of beryllium sensitization to chronic beryllium disease.
Seidler A; Euler U; Müller-Quernheim J; Gaede KI; Latza U; Groneberg D; Letzel S
Occup Med (Lond); 2012 Oct; 62(7):506-13. PubMed ID: 22705916
[TBL] [Abstract][Full Text] [Related]
19. Beryllium-specific CD4+ T cells induced by chemokine neoantigens perpetuate inflammation.
Falta MT; Crawford JC; Tinega AN; Landry LG; Crawford F; Mack DG; Martin AK; Atif SM; Li L; Santos RG; Nakayama M; Kappler JW; Maier LA; Thomas PG; Pinilla C; Fontenot AP
J Clin Invest; 2021 May; 131(9):. PubMed ID: 33630763
[TBL] [Abstract][Full Text] [Related]
20. Immunologic Effects of Beryllium Exposure.
Fontenot AP
Ann Am Thorac Soc; 2018 Apr; 15(Suppl 2):S81-S85. PubMed ID: 29676647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
